Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.
Latent Epstein-Barr virus (EBV) infection and growth transformation of B lymphocytes is characterized by EBV nuclear and membrane protein expression (EBV nuclear antigen [EBNA] and latent membrane protein [LMP], respectively). LMP1 is known to be an oncogene in rodent fibroblasts and to induce B-lym...
Guardat en:
| Publicat a: | J Virol |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1990
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC249392/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2157887/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.64.5.2309-2318.1990 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|